用人工智能驱动的对子宫内膜癌的发现:大数据时代的深度生成建模和分子模拟
Israr Fatima1, Abdur Rehman1, Zhibo Wang1
1Center of Bioinformatics, College of Life Sciences, Northwest A&F University, Shaanxi, 712100, Yangling, China.
Journal of computer-aided molecular design
|January 12, 2026
概括
人工智能 (AI) 通过设计用于子宫内膜癌的新分子来加速药物发现. 这个AI管道确定了强大的抑制剂,向具有高结合亲和度和稳定性的关键癌症蛋白.
科学领域:
- 在瘤学瘤学.
- 计算化学计算化学
- 药物发现 药物发现 药物发现
背景情况:
- 子宫内膜癌 (EC) 治疗需要新的策略.
- 针对AKT1,ESR1,Connexin-43和CTNNB1等关键蛋白质对于EC治疗至关重要.
- 将人工智能 (AI) 与分子建模相结合,可以加速发现新的抗癌剂.
研究的目的:
- 开发一种人工智能驱动的生成管道,用于设计针对子宫内膜癌的主要蛋白质的新型类分子.
- 确定具有高结合亲和力和稳定性对EC标的强基抑制剂.
- 为了评估设计分子的药物相似性,结合亲和力,稳定性和药理动力学特性.
主要方法:
- 使用一种生成管道,结合了深度强化学习 (DRL),生成对抗网络 (GAN) 和变异自动编码器 (VAE).
- 产生了14200多个类似的结构,以药物相似性和结构标准进行过.
- 采用深度学习增强的对接,分子动力学 (MD) 模拟和WaterSwap免费能源计算进行选和验证.
- 进行ADMET预测,以评估药物动力学特性和毒性.
主要成果:
- 与参考抑制剂相比,确定了排名第一的,gitoxoside和9-fluoro-11,与AKT1的结合亲和力相比,其结合亲和力更强.
- 对针对CTNNB1和ESR1目标的设计分子观察到高亲和相互作用.
- 模拟MD证实了复杂稳定性 (RMSD<2.5 Å) 和有利的结合能 (-34到-37 kcal/mol).
- 对于大多数候选药物,ADMET预测表明可接受的药物动力学特征和低毒性.
结论:
- 由人工智能驱动的管道有效地探索化工空间,以快速识别治疗候选者.
- 开发的基于和二的抑制剂显示出强大的结合 afinity 和稳定性对EC目标.
- 人工智能辅助的体设计为下一代子宫内膜癌治疗提供了一个可扩展和具有成本效益的战略.
相关概念视频
02:43Mouse Models of Cancer Study
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
02:43Mouse Models of Cancer Study
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...